DARZALEX 20 mg/mL concentrate for solution for infusion. *

  • Company:

    Janssen Sciences Ireland
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/16/1101/001 100 mg in 5 mL L01XC24 Concentrate for solution for infusion EU/1/16/1101/002 400 mg in 20 mL L01XC24 Concentrate for solution for infusion